Bryan, so you buy it then

PVTHSD92 I suppose you should sell

This is about a month or two late

investortrader88, Thanks. The shareholdings reported are sporadic with dates. Some are as of March 2019 and others as of April 6 2020. I too try to keep track but none are really up to date. Mine is from Shareinvestor

macgyver11, once holding are below 5%, company needn't report to Bursa.

KRISHNAN TATPARANANDAM ANANDA 34.834%
Permodalan Nasional Bhd. 13.004%
Karisma Mesra Sdn. Bhd. 4.018%
The Vanguard Group, Inc. 2.092%
Norges Bank Investment Management 1.913%
Employees Provident Fund 1.816%
Wijaya Sinar Sdn. Bhd. 1.339%
Dimensional Fund Advisors LP 1.324%
APG Asset Management NV 1.179%
TAN YU WEI 1.055%
Urusharta Jamaah Sdn. Bhd. 0.884%
Wijaya Baiduri Sdn. Bhd. 0.765%
Hong Leong Asset Management Bhd. 0.622%
CHRISTENSON GARY NEAL 0.594%
Maybank Asset Management Sdn. Bhd. 0.504%
LICHOTA ROBERT 0.355%
OOI CHIN HOCK /BUMI/ 0.349%
ABN AMRO Investment Solutions SA 0.341%
SAW CHAI SOON 0.340%
TAN YU YEH /BUMI/ 0.332%

Hi investortrader 88, the top 20 shareholder list you kindly shared. Would you happen to know as of when ie date? Thank you

Imagine demand for gloves has increased by an enormous 50%,while supply is limited to an only 20% increase and this quick squeeze cannot be-rectified overnight but only incrementally resulting in hand over fist rush for gloves with increasing ASPs. In the west its politically sensitive and heads may roll for failing to manage this health emergency, cost becomes an afterthought.

Top Glove has declared its rationing supplies to client ( customer isn't king ). Hospitals were in just in time mode for supplies before the pandemic but post it the UK and the US are stockpiling. This has compounded and expect a prolonged demand till and after vaccine is found.

Testing and tracing etc, Africa at cross road with the pandemic, a return of the virus in the fall in the west ..unabated demand. Plays right into the hands of PPE companies. It might remake companies. A supercycle

Its worth more that 25 sen but then again time will tell. I have bought plenty.

gnath@77 sage advice mate

This is an ATM for the major shareholders

Choivo Capital has made a valiant effort and credit to him for putting it out. Critical are his assumptions and that is subjective and only time will bear it out. A brave effort nevertheless

last time it happened it took 8 months to get Comfort's name off the list

Hartalega's net profit margin is in excess of 15 % and and its new plant/s is the size of one Careplus glove output.

Most of the other glove counters are in expansion mode and hence higher PE. For now Careplus' net profit margin averages less than 5% over the last 5 years ( excluding the last which was a loss) and no mention of expansion plans. Rubberex margins are equally as poor on average but it has in place an expansion plan.Comfort's is about 8% averaged over 5 years and with an expansion plan ( seasoned mgmt). This is just a quick sketch on why the others are taking off and Careplus for now remains rangebound. Price is based on a discounting mechanism.

Perhaps this quarter and next would be an inflection point but we will have to wait and see how it pans out.The Brazil situation should favour it. In a nutshell it is not firing on all cylinders but it has latent potential if mgmt get it right with operations.

Hi poseidon80, there is so much conjecture but RHB reckons the ePLKS may be retendered.

But noticing how much Wong has bought today has given me some confidence things aren't as bad as RHB's opinion

Good

“It is worth noting that the incumbent has been given a month’s extension on the online renewal of temporary employment pass for foreign workers (ePLKS), prompting the market to speculate that the lucrative contract could be up for tender soon.”

RHB's analyst

Totally concur

Hi daretocutandchange, if there was to be a significant hike in production it would have a mention in the qtrly report. None was stated in the latest qtrly. I think if based on current ops and is loss making then adding extra production should be in the back burner till current operations become profitable. That would be the right thing to do. However I will hasten to add that with Ansell, Careplus has potential.

Careplus glove production: Careglove 2.4 billion, CMSB 1.32 billion, Rubberglove 0.42 billion. Only CMSB has JV with Ansell and will be equity accounted. CMSB has been loss making so far and needs a revamp.

2nd para limits it to the annual report..hmmm fickle

OTHERS Careplus Group Berhad ("Careplus" or "the Company") - Extension of Time for Issuance of Annual Report
CAREPLUS GROUP BERHAD

Type Announcement
Subject OTHERS
Description Careplus Group Berhad ("Careplus" or "the Company")
- Extension of Time for Issuance of Annual Report
Following the Movement Control Order (“MCO”) period from 18 March 2020 to 28 April 2020 as announced by the Government to contain the spread of the COVID-19 outbreak in Malaysia, Bursa Malaysia Securities Berhad (“Bursa Securities”) had on 16 April 2020 granted an extension of time until 30 June 2020 for listed corporations to issue their quarterly reports and annual reports that include annual audited financial statements and the auditors' and directors' reports (“Annual Report”), which are due by 30 April 2020 and 31 May 2020.

In consideration of the challenges facing by the Group during the current situation, the Board of Directors of Careplus wishes to inform that Careplus will utilise the extension of time granted by Bursa Securities for issuance of its Annual Report for the financial year ended 31 December 2019 by 30 June 2020, provided that the MCO period is not extended further by the Government.

This announcement is dated 30 April 2020.

not too inspiring

You are right

I suspect it's the Ansell factor

S5 holding company controlled by Wee Choo Keong ( ex DAP)

MYEG to launch one-stop portal for employers to manage COVID-19 screening for their workforce

may not achieve much with a cash call at these prices

https://www.asiasentinel.com/p/maybulk-before-and-after-posh?utm_campaign=post&utm_medium=web&utm_source=copy

pa We need to tell the truth and shame the devil. All the best and let us all move on

Another con job is Mulpha.

https://www.asiasentinel.com/p/maybulkposh-what-happened-to-the-cash?utm_campaign=post&utm_medium=web&utm_source=copy

It is nearly a decade and smart investors have long memories on quality of mgmt

Sir CNLim, Perhaps you let emotion take charge if your investment strategy. We dont lose. Seek out good mgmt snd be objective and rationalise your arguments

another con job. Investors had great hope but have waited and waited. Robert Kuok
linked company; and many believed it was an investment. What a loss of faith

Enquest break even at USD27 for 2021, fingers crossed it survives this crisis for Armada's sake

shareholders ought to be informed

Invest_168 spot on

just about over a third of the world is housebound. This pandemic may last over a month , in the UK it has been suggested about three months; so let us be a bit more cautious.

thanks Sparrow

Test kits from South Korea have arrived along with another 100,000 FDA-approved kits from China

So where is MYEG's test kit.

Caution is the order of the period

LONDON (Reuters) - EnQuest (ENQ.L) aims to break even this year at $38 a barrel and does not expect to restart its Heather and Thistle/Deveron fields, which produced 6,000 barrel of oil equivalent per day (boed) last year, the British North Sea oil and gas producer said on Thursday.

EnQuest said it expected to produce between 57,000 and 63,000 boed this year, even after slashing operating costs by 30% to $375 million and investment cuts of $80 million (69.58 million pounds) to $150 million.

It added its 2021 production is likely to be impacted by these cuts, but that its breakeven was due to fall to around $35 a barrel.

EnQuest hedged a fifth of its 2020 output, or 2.9 million barrels, at an average floor price of $65 a barrel and 1.1 million barrels at an average floor of $52 a barrel.

“There are no further repayments of the Group’s senior credit facility due in 2020, with the facility maturing in October 2021,” EnQuest said, adding that its net debt was $1.367 billion at the end of February.

dont understand what KYY is up to.. full of rubbish

how impressive

RJ87 you done us a service in cornering these rogues

super volatile counter

sell down

QR perhaps not as good as expected

clown

I invested in it in 2007 based on assets etc etc then wrote to company secretary demanding info on its Australian business ( the bulk of its business) and suggesting it incorporate those accounts in a supplement in the Annual report and got an unhelpful response. Sold it then knowing it is not a transparent set up but play within the rules and not ethics.

Nothing has changed.